David Taylor, PhD
- 8Articles
- 60.2KReads
- 2010–2021Active
- 40Collaborators
- 253Citations
About
David Taylor, PhD, is affiliated with the Institute of Psychiatry in London, United Kingdom. Since 2010, Taylor has published extensively on topics including schizophrenia, schizoaffective disorders, Alzheimer disease, depression, mood disorders, neurology, patient care, and psychopharmacology. His work addresses antidepressant prescribing patterns and costs, pharmacogenetic-guided treatment in neuropsychiatric disorders, dose optimization for antipsychotics such as amisulpride, clozapine, quetiapine, and aripiprazole, and the clinical implications of drug plasma concentrations and receptor occupancy. Taylor frequently collaborates with co-authors such as Mark Davies, Mike Stedman, Adrian H. Heald, Anna Sparshatt, and Maxine X. Patel.
Publications
Patient-Practice Relationship and Antidepressant Prescribing
January 16, 2020
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
